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Abstract In vivo insulin sensitivity can be assessed using
‘‘open loop’’ clamp or ‘‘closed loop’’ methods. Open loop
clamp methods are static, and ﬁx plasma glucose inde-
pendently from plasma insulin. Closed loop methods are
dynamic, and assess glucose disposal in response to a
stable isotope labeled glucose tolerance test. Using
PPARa
-/- mice, open and closed loop assessments of
insulin sensitivity/glucose disposal were compared. Indi-
rect calorimetry done for the assessment of diurnal sub-
strate utilization/metabolic ﬂexibility showed that chow fed
PPARa
-/- mice had increased glucose utilization during
the light (starved) cycle. Euglycemic clamps showed no
differences in insulin stimulated glucose disposal, whether
for chow or high fat diets, but did show differences in basal
glucose clearance for chow fed PPARa
-/- versus SV129J-
wt mice. In contrast, the dynamic stable isotope labeled
glucose tolerance tests reveal enhanced glucose disposal
for PPARa
-/- versus SV129J-wt, for chow and high fat
diets. Area under the curve for plasma labeled and
unlabeled glucose for PPARa
-/- was &1.7-fold lower,
P\0.01 during the stable isotope labeled glucose toler-
ance test for both diets. Area under the curve for plasma
insulin was 5-fold less for the chow fed SV129J-wt
(P\0.01) but showed no difference on a high fat diet
(0.30 ± 0.1 for SV129J-wt vs. 0.13 ± 0.10 for PPARa
-/-,
P = 0.28). This study demonstrates that dynamic stable
isotope labeled glucose tolerance test can assess ‘‘silent’’
metabolic phenotypes, not detectable by the static, ‘‘open
loop’’, euglycemic or hyperglycemic clamps. Both open
loop and closed loop methods may describe different
aspects of metabolic inﬂexibility and insulin sensitivity.
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1 Introduction
Insulin sensitivity is an index, which measures the ability
of endogenous insulin to lower glucose in extracellular
ﬂuids by inhibiting hepatic glucose release and stimulating
the peripheral glucose consumption. Metabolic ﬂexibility is
the ability to dynamically switch between fatty acid and
carbohydrates as fuel sources, between the fasted and fed
states, respectively. It is deﬁned by the capacity of the body
or cells to match fuel oxidation to fuel availability and the
endocrine environment (Galgani and Ravussin 2008).
Disturbances in the reciprocal metabolic relationship
between glucose and fatty acid utilization has been postu-
lated to induce insulin resistance (reviewed in Kiens 2006).
Frameworks for in vivo insulin resistance and metabolic
inﬂexibility have been formulated to describe disturbances
underlying the metabolic syndrome and/or Type II diabetes
(Kelley 2005; Kelley and Mandarino 2000).
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DOI 10.1007/s11306-009-0190-2In vivo insulin sensitivity is typically determined by
the static ﬂux assessment of an euglycemic clamp, which
at a ﬁxed basal glucose level, measures peripheral glucose
disposal in response to an insulin increase (Ayala et al.
2006). Metabolic ﬂexibility is most easily assessed con-
tinuously during the diurnal cycle in mice using indirect
calorimetry (see Xu et al. 2006b for a detailed example).
The frameworks of metabolic ﬂexibility and insulin sen-
sitivity seem to be inter-dependent, or in the very least,
associated. It is not as yet clear, which may be affected
ﬁrst in the progression towards impaired glucose tolerance
and Type II DM. Skeletal muscle prefers fatty acids to
carbohydrate as a fuel source (Randle 1986; Randle 1995)
and clearly, a mixed diet containing high fat induces
insulin resistance, and metabolic inﬂexibility. Signaling
cascades are also affected by the intracellular accumula-
tion of lipids (Petersen and Shulman 2006; Shulman
2000) However, genetic defects possibly resulting in
metabolic inﬂexibility may not be insulin resistant. The
PPARa null mouse model, having inherent defect in fatty
acid oxidation (Desvergne et al. 2006) is such an exam-
ple. Euglycemic clamp assessment in the high fat fed
state shows no difference in glucose disposal for the
PPARa null mouse (Haluzik et al. 2004), despite glucose
tolerance test studies showing protection against high fat
diet induced hyperglycemia and hyperinsulinemia
(Guerre-Millo et al. 2001). Even so, these conventional
unlabeled glucose tolerance test studies showed no sig-
niﬁcant differences for PPARa null mice versus SV129J-
wt in the chow fed state. Thus the PPARa null mouse
model was considered to have a ‘‘silent’’ metabolic phe-
notype which could only be brought out by a high fat diet
(Guerre-Millo et al. 2001).
Stable isotope ﬂux phenotyping was able to discern the
underlying ﬂux compensations in the PPARa null mouse in
the chow fed state that maintained fuel homeostasis (Xu
et al. 2002, 2004). Utilizing stable isotope ﬂux phenotyping
methodology, this study assesses in vivo insulin sensitivity
in the setting of a dietary cause of metabolic inﬂexibility
(high fat diet), using the PPARa null-mouse as a model
system. Our study also addresses whether static (euglyce-
mic and hyperglycemic clamps) versus dynamic (stable
isotope labeled glucose tolerance test) methodology may
describe different aspects of insulin sensitivity, and how
pertinent these differences are to the assessment of meta-
bolic ﬂexibility. It was found that dynamic stable isotope
labeled glucose tolerance tests can assess ‘‘silent’’ meta-
bolic phenotypes that the static euglycemic clamp cannot.
Both the dynamic stable isotope labeled glucose tolerance
test, and static measurements of basal glucose clearance,
can aid indirect calorimetry for assessing metabolic ﬂexi-
bility/fuel utilization in mouse models of dysregulated
metabolism.
2 Materials and methods
2.1 Animals
Mice were obtained from The Jackson Laboratory (Bar
Harbor, ME). SV129J-wt and PPARa null mice ranged
from 3 to 4 months of age, with average body weight of
22 ± 3 g for wild-type and 21 ± 2 g for KO mice. Ani-
mals were fed standard laboratory chow diet (4.5% fat,
20% protein and 54.8% carbohydrate by weight) (PICOLab
Rodent Diet 20; 5053) and maintained under 12-h light/
dark conditions (6:00 AM/6:00 PM) for clamp and body
analysis studies, (7:00 AM/7:00 PM) for stable isotope
labeled glucose test and hepatic glucose production studies.
2.1.1 Stable isotope labeled glucose tolerance test (SiGTT)
and hepatic glucose production (HGP) studies
Around ten mice each of PPARa null, SV129J-wt males
maintained on chow diet before they were switched to
high fat/high carbohydrate diet (35% fat and 33% car-
bohydrate by weight, F3282; Bioserve, Frenchtown, NJ).
They were fed high fat diet for 4 weeks, before being
studied. Stable isotope labeled glucose tests and hepatic
glucose production studies were done as in our previous
studies (Xu et al. 2002, 2003, 2004, 2006a, 2006b).
Brieﬂy, mice were fasted at 7 PM and an intra peritoneal
injection of glucose was done (1.0 mg/g body weight,
containing 50% [6,6-
2H2]-glucose) at 10 AM next morn-
ing. Each point of the stable isotope glucose tolerance test
was the average of 5 mice. Blood samples for insulin and
glucose analysis were collected at various time points as
indicated in Fig. 3. [6,6-
2H2]-glucose was[98% enriched
and sterility/pyrogenicity tested by the manufacturer
(Cambridge Isotope Laboratories, MA). GC/MS analyses
of plasma glucose isotopomers during the stable isotope
labeled glucose tolerance test can be found in our previ-
ous paper (Xu et al. 2002, 2003, 2004). Brieﬂy 50–100 ll
of plasma were deproteinized, deionized, and dried. The
glucose was treated with hydroxylamine hydrochloride
and then acetic anhydride to create aldonitrile pentaace-
tate derivative, which was dissolved in 150 ll ethyl ace-
tate for GC/MS analysis.
2.1.2 Stable isotope assessment of hepatic glucose
production and clearance
Determination of hepatic glucose production was carried
out by constant infusion of [U-
13C6]-glucose (99% enri-
ched, Cambridge Isotope Laboratories, MA) through a
mini-osmotic pump (Alza model 2001D, duration 24 h)
(Xu et al. 2002). Four PPARa null and SV129J-wt males
each were examined at 16–18 weeks of age. Brieﬂy,
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123fasting of animals was initiated at 4 PM, and a mini-osmotic
pumps containing 0.25 mg/ll of [U-
13C6]-glucose was
quickly insertedtosubcutaneousspace ofananimalat7 PM
under *5% isoﬂurane. Blood samples were collected by
retro-orbital bleeding at 10 AM next morning. Hepatic glu-
cose production (HGP) rate was determined using the fol-
lowing equation: HGP (mg glucose/kg body weight/
min) = infusion rate 9 (1/ETracer - 1). In the basal state,
HGP = basal glucose disposal, and clearance is deﬁned as
(HGP/[Basal glucose]). The infusion rate (mg/kg/min) =
miniosmotic pump rate (8 ll/h calibrated by the manu-
facturer) 9 [U-
13C6]-glucose concentration (0.25 mg/ll)/
mouse body weight (kg). ETracer is the enrichment of plasma
[U-
13C6]-glucose determined by gas chromatography/mass
spectrometry (GC/MS) analysis. GC/MS conditions,sample
preparations for GC/MS analysis, and a detailed description
of equations and calculations for HGP can be found in our
previous papers (Xu et al. 2002, 2006a).
2.1.3 Euglycemic hyperinsulinemic and hyperglycemic
clamp studies
Clamp experiments were performed using mice at
12–14 weeks old, in chronically catheterized conscious
mice in the Mouse Metabolic Phenotyping Center at
Vanderbilt University Medical Center. Animals were fed
high-fat diet for 8 weeks euglycemic clamp or 3 weeks
hyperglycemic clamp, respectively. The catheters were
implanted in the carotid artery and jugular vein for
sampling and infusions, respectively. The surgical proce-
dures utilized are similar to those described previously
(Ayala et al. 2006). Animals were individually housed
after surgery, and body weight was recorded daily. The
success rate of the surgery and catheterization procedures
was *70%. Mice were allowed to recover from surgery
for at least 3–4 days and were only studied when body
weight was restored to within 10% of pre-surgery body
weight. All procedures performed were approved by the
Vanderbilt University Animal Care and Use Committee.
After 3–4 days of recovery, 4 h fasted conscious mice
underwent one of two protocols (n = 5–7 in all groups).
After basal sampling at time 0, insulin was continuously
infused at 2.5 mU kg
-1 min
-1 for the duration of the 2-h
study (euglycemic clamp). Blood glucose levels were
monitored using a HemoCue glucose analyzer (HemoCue;
Mission Viejo, CA). Glucose was infused at a variable
rate to maintain clamped blood glucose levels at 120 mg/
dl (EG clamp), and 220 mg/dl (HG clamp), a primed
(5 lCi) continuous (0.05 lCi/min) infusion 3-
3H glucose
was initiated 120 min (t =- 120 min) prior to initiating
the clamps. Plasma sampled prior just prior to the clamp
onset (t - 0
-) was used to calculate basal glucose dis-
posal and clearance. Then the tracer infusion rate was
increased to 0.1 lCi min at the onset of the clamp
(t = 0 min) and infused throughout the study. At
t = 120 min mice received a 13 mCi bolus of 2-deoxy
[
14C] glucose (2DG) to provide an index of muscle glu-
cose uptake (MGU) by measuring the accumulation of
2DG-phosphate (2DG-P). During the experimental period,
a continuous infusion of donor blood was used to replace
blood removed. After taking the last blood sample
(t = 145 min), mice were anesthetized with an infusion of
sodium pentobarbital. The adipose tissue, brain, liver,
gastronemius, soleus and vastus were excised, freeze-
clamped immediately in liquid nitrogen, and stored at
-70C until future tissue analysis.
2.1.4 Body composition
Body composition was determined for each animal by low
resolution nuclear magnetic resonance (NMR) Percentage
lean mass and fat mass were calculated as a proportion of
the total body weight of the animal. PPARa null (n = 10)
and SV129J-wt (n = 9) males were examined by NMR
prior to placing animals on a high fat diet and at 3 and
8 weeks on the high fat diet.
2.1.5 Indirect calorimetry
Metabolic parameters (n = 7–8/group) were measured
using an Oxymax (Columbus Instruments, Columbus, OH)
8 cage open circuit indirect calorimetry system.
Oxygen consumption (VO2) and the respiratory
exchange ratio (RER) were measured by an Oxymax
indirect calorimeter (Columbus Instruments, Columbus,
OH) with an air ﬂow of 0.75 l/min. VO2 is expressed as the
volume of O2 consumed per kilogram body weight per
hour. After 1 h, to allow for adaptation to the metabolic
chamber, VO2 was measured, starting at 10:00 AM, in
individual mice for 1 min at 15-min intervals for a total of
22 h under a consistent environmental temperature (22C).
The respiratory exchange ratio (RER) is the ratio of the
volume of CO2 produced to the volume of O2 consumed.
Mice were individually housed in the chamber for 48 h
with lights on from 0600 to 1800 in an ambient temperature
of 22–24C. Food was available ad libitum during the dark
cycle (feeding phase 1800–0600) and the light cycle
(fasting phase 0600–1800). Gas exchange measurements
were made under Oxymax system settings as follows: air
ﬂow, 0.6 l/min; sample ﬂow, 0.5 l/min; settling time,
6 min; and measuring time, 3 min.
All animal studies were performed under approved
institutional protocols and according to guidelines estab-
lished in the Guide for the Care and Use of Laboratory
Animals.
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1232.1.6 Biochemical/serum analysis
The plasma glucose level was determined by COBAS
MIRA analyzer (Roche, Montclair, NJ) using Glucose UV
Reagent (catalog no. 80017, Raichem, San Diego, CA).
Plasma insulin was determined using ultra sensitive rat/
mouse Insulin ELISA Kit (Crystal Chem. Inc., Cat#
90060).
2.1.7 Statistical analyses
All data were expressed as mean ± SEM, except for data
in Table 1 and the inset tables in Figs. 4 and 5, presented as
mean ± standard deviation (SD) Analyses for the signiﬁ-
cance of differences were performed using Student’s t-test.
3 Results
3.1 The PPARa null mouse is metabolically inﬂexible
Since the previous metabolic studies utilizing clamps
(Haluzik et al. 2004) or unlabeled intra-peritoneal glucose
tolerance tests (Guerre-Millo et al. 2001) used the PPARa
null mouse on a SV129J background, this background was
used for this study. The inﬂuence of PPARa on metabolic
ﬂexibility was ﬁrst examined by indirect calorimetry.
Figure 1 shows that in the chow fed state, glucose utili-
zation substitutes for fatty acid utilization during the light
cycle. In the light cycle, fatty acid utilization normally
increases with time, as seen here for the SV129J-wt by the
respiratory exchange ratio (RER ¼ VCO2=VO2) progres-
sively decreasing from 0.95, just when the dark cycle ends,
to 0.78 at the end of the light cycle. For the PPARa null
mice, there is an increase in the respiratory exchange ratio
(RER) from 0.85 to 0.95 during the light cycle, and
remains elevated during most of the light cycle, a state of
metabolic inﬂexibility.
High fat feeding for 8 weeks represents a chronic del-
eterious stimulus for assessment of PPARa deﬁciency on
fuel utilization. After 8 weeks on a high fat diet, oxygen
consumption (VO2) (Fig. 1), calculated (default by the
Oxymax software) per kg of total body weight was lower
for the PPARa null mice, suggesting a lower metabolic
rate. The diurnal substrate utilization appears identical for
both PPARa null and the SV129J-wt mice.
However, oxygen consumption (VO2) normalized for
lean body mass is virtually identical for the PPARa null
and wild type mice (data not shown). Figure 2 shows the
assessment of fat and muscle by low resolution quantitative
NMR. Lean muscle mass is not signiﬁcantly different for
the PPARa null and SV129J-wt mice.
These results suggest that compensations have occurred
in response to this high fat diet, a case of extreme substrate
excess. These compensations allow for the matching of
metabolic rate/substrate utilization, but at the cost of
weight gain for the PPARa null mice. These results are
consistent with the mice having a ﬁxed energy need,
matched for SV129J-wt and PPARa null mice, independent
of their diet, and dependent on lean muscle mass. The
results also indicate that while indirect calorimetry can be
useful in the detection of ‘‘metabolically silent’’ pheno-
types, measurement of simply the diurnal variation in fuel
utilization or oxygen consumption cannot assess the
underlying fuel compensations that maintain whole body
energy needs.
Table 1 Effect of diet on dynamic glucose disposal, as assessed using stable isotope glucose tolerance test (either a
13C1,2 glucose or a [6,6-
2H]-
glucose)
Chow diet High fat diet
WT (n = 6) KO (n = 5) WT (n = 6) KO (n = 5)
Body weight (mg) 27 ± 1.9 31 ± 1.9** 32 ± 3.0 34 ± 2.9*
Fasting plasma glucose (mg/dl) 150 ± 25 109 ± 27* 169 ± 22 97 ± 18***
Fasting plasma insulin (ng/ml) 0.16 ± 0.06 0.32 ± 0.09** 0.462 ± 0.12 0.26 ± 0.11*
AUC plasma glucose (mg/dl 9 h) 237.1 ± 25.44 125.2 ± 20.92** 352.7 ± 29.01
§ 191.5 ± 16.52***

AUC plasma insulin (ng/ml—h) 0.11 ± 0.054 0.53 ± 0.20* 0.30 ± 0.12 0.13 ± 0.10
2 9 AUC plasma [6,6-
2H2] glucose (mg/dl-2 h) 128 ± 12 96 ± 6* 244 ± 14 162 ± 18***
AUC plasma [1,2-
13C] glucose (mg/dl 9 h) – – 289.3 ± 11.1 171.9 ± 12.55***
KO represents PPARa
-/- and WT represents SV129J-wt. The areas under the curve (AUC) are compared for plasma glucose, [6,6-
2H2]-glucose
and [1,2-
13C] glucose and insulin, between WT and PPARa
-/- mice during the 2-h time course of intraperitoneal SiGTT (1 mg/g body weight).
For the [6,6-
2H2]-glucose tolerance test, since the glucose injected was only 50% enriched in [6,6-
2H2]-glucose, a factor of 2 is necessary for
comparison of the [6,6-
2H2]-glucose area under the curve to the total glucose area under the curve. [1,2-
13C] glucose has already been used by us
to evaluate PPARa
-/- mice under chow fed conditions (Xu et al. 2004) and so this was not repeated here. Data are presented as mean ? SD.
*** P\0.001, ** P\0.01, * P\0.05 between the respective WT and PPARa
-/- mice and
§ represents P\0.0001 for chow versus high fat
fed WT and
 represents P\0.01 for chow versus high fat fed PPARa
-/- mice determined by student’s t-test
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1233.2 Evaluation of the ‘‘silent’’ PPARa null mice
metabolic phenotype—dynamic versus static
assessment of glucose disposal
The increased reliance on carbohydrate as a primary fuel for
the PPARa null mice shown by indirect calorimetry
(Fig. 1), led us to examine glucose disposal in the chow fed
versus high fat fed PPARa null mouse models. Two
methods were compared. One,using a stable isotope labeled
glucose tolerance test shown to evaluate ‘‘dynamic’’ glu-
cose disposal during the glucose tolerance test. Stable iso-
tope labeled glucose tolerance tests has been effective in
evaluating ‘‘silent’’ metabolic phenotypes (Xu et al. 2004,
2006a). The other were traditional, gold standard methods,
that give a ‘‘static’’ evaluation of glucose disposal at ﬁxed
glucose levels, the euglycemic-hyperinsulinemic (EU)
clamp, and the hyperglycemic (HG) clamp. The euglycemic
clamp accurately evaluates glucose disposal for basal glu-
cose at a ﬁxed high insulin level. However, the prior use of
the euglycemic clamp in the PPARa null mouse model
revealed no difference in glucose disposal under high fat
feeding conditions (Haluzik et al. 2004). This is in contrast
to an unlabeled glucose tolerance test that showed a smaller
glucose excursion with a smaller insulin response during a
glucose tolerance test for the high fat fed PPARa null versus
wild type mice (Guerre-Millo et al. 2001).
For this study, we used a stable isotope labeled intra
peritoneal glucose tolerance test that employed either
Fig. 1 Indirect calorimetry of PPARa null and SV129J-wt mice
during the fasted to fed transition. The units for the time axis indicate
the dark cycle is 12 h in duration. RER is dimensionless, and oxygen
consumption is expressed as ml of O2 consumed per kg of whole body
mass per min. For chow fed mice, energy expenditure is preserved in
the absence of PPARa, but diurnal substrate utilization is affected by
the absence of PPARa. There are no signiﬁcant differences in VO2 for
high fat fed PPARa null and SV129J-wt mice when normalized by
lean muscle mass, as opposed to the differences seen here when
normalized by their whole body mass (see text and Fig. 2). Data are
mean ± SEM. * P\0.05, ** P\0.01, *** P\0.001 PPARa null
versus SV129J-wt mice
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123[1,2-
13C]-glucose or [6,6-
2H]-glucose for glucose disposal
at 1 mg glucose/g body weight (see Sect. 2). Figure 3 and
Table 1 summarize a comparison of the results shown.
The data demonstrates the utility of using this stable
isotope labeled glucose tolerance test over a conventional
glucose tolerance test. For the chow fed studies, the area
under the curve for plasma glucose (labeled and unlabeled)
for the SV129J-wt during the glucose tolerance test is
signiﬁcantly higher than the area under the curve for
[6,6-
2H]-glucose for the PPARa null mice. This suggests
that either the PPARa null mice have increased glucose
disposal, or hepatic glucose production may be less sup-
pressed for the SV129J-wt than the PPARa null mice
during the test. The data implies some component of both
may be evident. The area under the curve for plasma
insulin was 5-fold less for the SV129J-wt in comparison to
the PPARa null mice. This suggests the possibility of less
inhibition of hepatic glucose production during the
[6,6-
2H]-labeled glucose tolerance test for the wild type.
The PPARa null mice had a similar area under the curve
for total and [6,6-
2H] plasma glucose. However, the
PPARa null mice also had a lower area under the curve for
[6,6-
2H] glucose than the SV129J-wt mice. This suggests a
greater rate of glucose disposal for the chow fed PPARa
null mouse. In contrast, for the SV129-wt mice the area
under the curve for plasma [6,6-
2H]-glucose during the
glucose tolerance test is nearly 2-fold less than the area
under the curve for total plasma glucose (labeled and
unlabeled). This is also consistent with less inhibition of
hepatic glucose production during the [6,6-
2H]-labeled
glucose tolerance test for the SV129J wt mice.
Figure 3 and Table 1 indicates that after 4 weeks of
high fat feeding, the PPARa null mice showed increased
glucose disposal versus the SV129J-wt. Suppression of
hepatic glucose production during the stable isotope
labeled glucose tolerance test was evident for the high fat
fed PPARa null mice, which had similar area under the
curves for the total (labeled and unlabeled) and [6,6-
2H]
plasma glucose. However, during the glucose tolerance
test, the SV129J-wt had a *40% increase in the area under
the curve for total glucose versus the [6,6-
2H] glucose, as
opposed to a 18% increase for the same measurements for
the PPARa null mice (Table 1). This is consistent with the
ﬁnding that the high fat fed SV129J-wt had a decreased
suppression of hepatic glucose production during the
[6,6-
2H]-glucose tolerance test. Increased peripheral insu-
lin sensitivity for the high fat fed PPARa null mouse model
is supported by stable isotope labeled glucose tolerance test
glucose disposal measurements. The areas under the curves
for both [6,6-
2H] glucose or the [1,2-
13C] glucose was
decreased by *30% for high fat fed PPARa null mice
compared to the high fat fed SV129J-wt mice, for an
identical area under the curve for plasma insulin.
As reviewed by Wolfe and Chinkes (Wolfe 2005)
hepatic glucose uptake of [6,6-
2H2]-glucose generally leads
to loss of the deuterium label, when 3-carbon pyruvate
produced is converted to oxaloacetate and when malate is
converted to fumarate in the TCA cycle. Therefore, the
[6,6-
2H2]-glucose time course during the [6,6-
2H]-glucose
tolerance test represents glucose disposal with minimal, if
any, re-circulation through the TCA cycle. However, while
theoretically [1,2-
13C] glucose in the (
13C1,2-glucose tol-
erance test) can re-circulate through the TCA cycle, Cori
cycle, or the hepatic pentose cycle, the area under the curve
for [1,2-
13C] glucose during the
13C1,2 glucose tolerance
test was similar for both the SV129J-wt and PPARa null
for these high fat fed mice. This indicates that there was
minimal re-cycling of the [1,2-
13C]-glucose tracer, and that
the use of the
13C1,2-labeled glucose tolerance test was
equivalent to the [6,6-
2H]-labeled glucose tolerance test, at
least for the conditions examined here.
The differences seen in the muscle glucose disposal
response during the stable isotope labeled glucose toler-
ance test were further clariﬁed using the euglycemic-
hyperinsulinemic (EU) clamp, and the hyperglycemic
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Fig. 2 Body composition studies. PPARa null mice gain weight
more quickly on a high fat, high carbohydrate diet (Bioserve Product#
F3282, see Methods Sect. 2). The fat mass is higher for the PPARa
null in comparison to the SV129J-wt mice. Lean muscle mass is not
signiﬁcantly different for the PPARa null and wild type mice. Data
are mean ± SEM. * P\0.05, ** P\0.01, *** P\0.001 PPARa
null versus SV129J-wt mice
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123clamp (HG). The euglycemic clamp gives an ‘‘open loop’’
measurement of insulin sensitivity, as glucose disposal is
measured at basal insulin in response to a given insulin step
infusion. The hyperglycemic clamp can be considered to be
a ‘‘controlled’’ version of a glucose tolerance test, as
hyperglycemic levels are reached for the entire clamp study
that are similar to peak levels of glucose during a glucose
tolerance test, and the insulin levels seen during the
hyperglycemic clamp are responsive to the level of
glycemia.
Euglycemic clamps were done in chow fed SV129J-wt
and PPARa null mice, and after 8 weeks of high fat fed
feeding. Hyperglycemic clamps were done after 3 weeks of
high fat feeding (Table 2). The effect on glucose disposal
and rate of appearance (Ra) in the absence of PPARa for
these conditions is summarized in Table 2.
The greatest difference seen in the euglycemic and
hyperglycemic clamp studies reﬂect the basal values, rather
than the euglycemic or hyperglycemic clamped states
themselves. While the basal glucose values (6.5 h fasted)
were similar in the chow fed state, the basal glucose values
trended lower for the PPARa null mice versus SV129J-wt
whether for 3 weeks or 8 weeks of high fat fed feeding. For
all the animals placed on a high fat diet, total glucose ﬂux
decreases in wild type and PPARa null mice with time,
reﬂectedintheglucoseclearance(Fig. 4).Glucoseclearance
ishigherforPPARanullmiceinthebasalchowfedstate,and
with high fat fed feeding glucose clearance decreases for
both. Statistically there is no difference in glucose clearance
for KO versus SV129J-wt at 3 or 8 weeks.
Basal glucose clearance in response to an 18 h fast,
calculated from Alzet mini-pump hepatic glucose
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Fig. 3 The effect of the presence or absence of PPARa on glucose
disposal during a stable isotope labeled glucose tolerance test in
response to chow diet versus 4 weeks of high fat feeding. Time course
of plasma glucose, insulin and ([6,6-
2H] glucose isotopomers from
their basal levels is shown. The broken lines represent PPARa null
mice and the solid lines represent the SV129J-wt. Each point shown
represents the mean ± SEM with ﬁve animals in each group. The two
tailed t test was used for all statistical analyses. * P\0.05,
** P\0.01, *** P\0.001 PPARa null versus SV129J-wt mice
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123production experiments (U
13C glucose), presents a differ-
ent picture (Fig. 5). The basal glucose clearance and
hepatic glucose production, between SV129J-wt and
PPARa null mice as assessed using the Alzet U
13C glucose
mini-pump, do not differ for the chow fed state. However,
hepatic glucose production is decreased, and glucose
clearance is increased, for the PPARa null mice versus
SV129J-wt in the high fat fed state (Fig. 5).
Hyperglycemic clamps were done to assess whether the
pancreatic b-cell had a primary defect in the high fat fed
state. A shorter high fat feeding period was used than the
euglycemic clamp (3 weeks), to examine an effect of high
fat feeding on the pancreatic b-cell in approximately the
same time frame as that used for the stable isotope labeled
glucose tolerance test. Again, the PPARa null mice were
hypoglycemic in the basal state with respect to the SV129J-
wt (85 mg/dl vs. 100 mg/dl, respectively, see Fig. 4) for
similar basal insulin (1.8 ± 0.9 ng/ml for the PPARa null,
1.2 ± 0.2 ng/ml for the SV129J-wt). However, in response
to a glucose infusion that raised the plasma glucose of both
groups of mice to approximately 225 mg/dl, the PPARa
null plasma insulin was 27.4 ± 8.1 ng/ml, and the SV129J-
wt plasma insulin was 32 ± 6.0 ng/ml (Table 2). This
indicates that there is an enormous insulin reserve in high
fat fed b-cells, regardless of the level of PPARa, when a
high constant glucose stimulus is used. This suggests a high
Table 2 Plasma glucose, insulin and clamp results on different weeks of high fat diet
Clamped (*80–120 min) 0 weeks (euglycemic clamp) 3 weeks (hyperglycemic clamp) 8 weeks (euglycemic clamp)
WT (n = 6) KO (n = 5) WT (n = 6) KO (n = 5) WT (n = 7) KO (n = 6)
Plasma glucose (mg/dl) 117 ± 5 123 ± 5 217 ± 3 228 ± 2 126 ± 6 130 ± 7
Plasma insulin (ng/ml) 3.3 ± 0.6 5 ± 0.7 32 ± 6.0 27.4 ± 8.1 3.7 ± 0.4 4.4 ± 1.4
GIR (mg/kg/min) 52 ± 46 9 ± 35 9 ± 14 4 ± 03 4 ± 5.4 34.2 ± 6.9
Ra (mg/kg/min) 80.5 ± 13 93 ± 11 49.1 ± 1 43.2 ± 1.1 32.4 ± 5.3 27.7 ± 2.2
Endo Ra (mg/kg/min) 27 ± 12 25 ± 8 -10.2 ± 1.0 -0.5 ± 1.0 -3.1 ± 4.9 -6.5 ± 6.6
KO represents PPARa
-/- and WT represents SV129J-wt. The table shows clamp results during a euglycemic (120 mg/dl) and 2.5 mU/kg/min
insulin and hyperglycemic (220 mg/dl) clamps. GIR represents glucose infusion rate, Ra represents rate of appearance of glucose. Data
represented are values ? SEM. A negative value for Endo Ra represents suppression of Endo Ra
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123fat induced defect in detecting transient insulin elevations
by the pancreatic b-cell during the stable isotope labeled
glucose tolerance tests, as the area under the curve for
plasma insulin does not reﬂect this. As seen in Table 1,w e
ﬁnd that there are no differences in the area under the curve
for plasma insulin for both the PPARa null and SV129J-wt
mice on a high fat diet, even given the substantial differ-
ences in glucose area under the curve for SV129J-wt versus
the PPARa null mice on a high fat diet.
4 Discussion
4.1 Advantages of combining static and dynamic
approaches for the assessment of in vivo insulin
sensitivity and metabolic ﬂexibility
This works suggests ways of combining static and dynamic
approaches for optimal assessment of compensatory
interactions that maintain fuel homeostasis. It also helps us
to determine how these compensatory interactions dictate
the development of metabolic ﬂexibility, and/or insulin
resistance. The PPARa null mouse model, due to an
inability to oxidize fatty acids, proved ideal for the testing
of these complementary approaches. As we have shown
here, the PPARa null mouse model is metabolically
inﬂexible. The present study characterizes the PPARa null
mouse on a SV129J background, as opposed to previous
studies on a C57BL/6 background (Xu et al. 2002, 2004). It
details the metabolic compensations that have evolved to
maintain fuel homeostasis secondary to an inability to
oxidize fatty acids, using both static (euglycemic and
hyperglycemic clamp clearance measurements (Fig. 4), or
Alzet osmotic mini pump measurements of glucose clear-
ance (Fig. 5)), and dynamic (stable isotope labeled intra
peritoneal glucose tolerance test) methodologies.
Both dynamic assessment of glucose disposal, and static
assessment of basal glucose clearance after an overnight
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123fast, reveal the high fat fed PPARa null mice have
increased glucose ﬂux. Using dynamic ﬂux methods, we
see that, on a SV129J background, the chow fed PPARa
null mice has a 5-fold greater insulin response during the
stable isotope labeled glucose tolerance test than the wild
type, supporting the observation of a primary defect in
over-secretion of insulin in the PPARa null mice, on this
background (Gremlich et al. 2005). The increased dynamic
glucose disposal for the PPARa nulls on a C57BL/6 mouse
background occurs with identical insulin secretion during a
stable isotope labeled glucose tolerance test for the C57BL/
6 background (Xu et al. 2004), indicating increased
‘‘peripheral insulin sensitivity’’ (considering only the glu-
cose and insulin values). This differs for the SV129J
background in the chow fed state, as in the chow fed state,
there is a 2-fold decrease in the area under the curve for
glucose for the PPARa null mice with a 5-fold increase in
the area under the curve for insulin and a 60% increase in
basal insulin versus the respective SV129J-wt (Table 1).
The absence of PPARa, whether on a C57BL/6 or SV129J
background, results in increased dynamic glucose disposal.
For the PPARa null mouse, on a SV129J background, the
increased dynamic glucose disposal may be dependent on
the increased insulin secretion seen during the stable iso-
tope labeled glucose tolerance test. This suggests that
rather than considering the compensatory mechanisms that
preserve fuel homeostasis in terms of changes of insulin
sensitivity, one should consider compensatory ﬂux mech-
anisms that determine dynamic glucose disposal and met-
abolic ﬂexibility. Further, genetic background has great
relevance in determining the ability of organs, such as the
pancreas, to adaptively contribute to compensatory ﬂux
mechanisms. The smaller insulin response by the PPARa
null mice on the C57BL/6 background genetically may be
due to the decrease in b-cell nicotinamide nucleotide
transhydrogenase (Nnt) seen for the C57BL/6 background
(Freeman et al. 2006). PPARa null mouse on both SV129J
and C57BL/6 backgrounds has increased peripheral glu-
cose disposal which compensates for the impaired fatty
acid oxidation in the chow and high fat fed states, but
insulin responses are seen to be different between the two
backgrounds only in the chow fed state. Moreover, there is
increased peripheral insulin sensitivity seen for the PPARa
null mice in the high fat fed state, but only when assessed
dynamically by the stable isotope labeled glucose tolerance
test, not with the euglycemic clamp (Table 1, Fig. 3).
Thestableisotopelabeledglucosetolerancetest,byvirtue
of closed loop and stable isotope assessment of the dynamic
response, has advantages in the assessment of glucose dis-
posal over static clamp studies. Euglycemic clamp assess-
ment is an open loop method that requires normalization of
the basal glucose values used during the comparative
assessments. For the PPARanull mouse, ifthe ‘euglycemic’
clamp assessment were to be done at the SV129J wt value,
this value would be hyperglycemic, as the basal glucose
valueforthePPARanullmouseislowerthantheSV129Jwt.
Also,theeuglycemicclampneutralizestheadaptiveincrease
in insulin secretion that occurs for the PPARa null mouse,
relative to wt (Table 1), and its effect on glucose disposal.
Genetic background, for the PPARa null mouse, determines
the means by which enhanced glucose disposal occurs in the
face of a deﬁciency in fatty acid oxidation.
The implications of the differences implicit in static and
dynamic assessments may be profound when designing a
phenotyping study. Looking at glucose disposal as a func-
tion of the insulin response during a stable isotope labeled
glucose tolerance test, or the insulin level during an
euglycemic clamp, apparently yields different estimates of
whole body insulin sensitivity. Both clamp and stable iso-
tope glucose tolerance test methods have utility. Examining
‘‘closed loop’’ glucose tolerance tests cannot answer how
glucose disposal may change for a given increment in
plasma insulin, as can be done with the euglycemic clamp.
The dynamic ‘‘closed loop’’ stable isotope labeled glucose
tolerance test, however, may be ideal for initial assessment
of hepatic and/or peripheral insulin resistance, and may
yield information concerning adaptive, responses that
maintain overall fuel homeostasis that even indirect calo-
rimetry cannot detect. The results of this study may also
provide investigators a rationale for use of dynamic meth-
ods for screening for initial assessments of insulin resis-
tance before clamp studies are done, as a ‘‘triage’’ to help
with decisions in phenotyping assessments.
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